Publications

November 2006 (Revised December 2011)
Case

HCA, Inc. (A)

By: Richard S. Ruback

Focuses on the buyout of HCA by three private equity firms: Bain Capital, KKR, and Merrill Lynch Global Private Equity. It provides an opportunity to discuss a variety of issues related to leveraged buyouts including the process, the role of private equity, the... View Details

Keywords: Leveraged Buyouts; Private Equity; Investment; Business and Shareholder Relations; Conflict and Resolution; Valuation

August 2011 (Revised October 2015)
Case

Boardroom Battle Behind Bars: Gome Electrical Appliances Holdings—A Corporate Governance Drama

By: William C. Kirby and Tracy Yuen Manty

Despite widespread news of the incarceration of Gome Electronics' CEO, Huang Guangyu, Bain Capital felt they carefully undertook due diligence before making a significant investment in the company. The venture capital firm was confident that it and the current... View Details

Keywords: China; Legal Aspects Of Business; Corruption; Risk; Corporate Governance; Crime and Corruption; Power and Influence; Risk Management; Business and Shareholder Relations; Venture Capital; Ethics; Governing and Advisory Boards; Governing Rules, Regulations, and Reforms; Values and Beliefs; Private Equity; China

November 2012 (Revised January 2014)
Case

HCA, Inc. LBO Exit

By: Victoria Ivashina

This case discusses the events following the 2006 $33.2 billion buyout of Hospital Corporation of America (HCA) by a consortium of private equity firms, including Bain Capital, KKR, and Merrill Lynch's private equity arm. The case highlights some of the core features... View Details

Keywords: Entrepreneurship; Finance; Stockholders; Dividends; Private Equity; Initial Public Offering

Career Coach

Okan Okutgen

manufacturer. He has also experience of consultancy from Bain & Company. Okan also serves as a mentor to startups as they help try to get seed funding in accelerators. Okan has a Mechanical and Aerospace Engineering degree, but has... View Details

November 2008 (Revised April 2010)
Case

The Bridgespan Group: Chapter 2

By: Allen S. Grossman, Naomi Greckol-Herlich and Cathy Ross

The Bridgespan Group was launched in 2000 by management consulting group Bain & Company as a nonprofit focused on strategy consulting for nonprofits and philanthropists. Over the next eight years, Bridgespan expanded its services to include executive search, knowledge... View Details

Keywords: Philanthropy and Charitable Giving; Growth and Development Strategy; Service Operations; Corporate Social Responsibility and Impact; Nonprofit Organizations; Expansion; Consulting Industry

23 Nov 1999
Research & Ideas

What’s Your Strategy for Managing Knowledge?

collectively arrive at deeper insights by going back and forth on problems they need to solve. Marcia Blenko, for example, a partner in Bain's London office, had to consider a difficult strategy problem for a large British financial institution. The client wanted View Details

Keywords: by Morten T. Hansen, Nitin Nohria & Thomas Tierney; Consulting

April 2018
Supplement

Celgene

By: Malcolm Baker and Emily R. McComb

In February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with... View Details

Keywords: Life Sciences; Biotechnology; Public Market Investing; Celgene; Revlimid; Hedge Fund; Growth Stocks; Valuation; Investment; Decision Choices and Conditions; Analysis

06 Dec 2020
News

Neera Tanden, Biden’s pick for budget chief, runs a think tank backed by corporate and foreign interests

07 Nov 2014
News

INCAE Observes 50th Anniversary at Celebration at Harvard Business School

March 2018 (Revised May 2018)
Case

Celgene

By: Malcolm Baker and Emily McComb

In February 2011, Adam Koppel, a managing director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with... View Details

Keywords: Life Sciences; Biotechnology; Public Market Investing; Celgene; Revlimid; Hedge Fund; Growth Stocks; Valuation; Investment; Decision Choices and Conditions; Analysis; Biotechnology Industry